Veterinary Imaging Market is estimated to be US$ 3.00 billion by 2030 with a CAGR of 7.3% during the forecast period

 

Veterinary Imaging Market accounted for US$ 1.5 billion in 2020 and is estimated to be US$ 3.00 billion by 2030 and is anticipated to register a CAGR of 7.3%. Veterinary imaging is a branch of veterinary medicine, veterinary imaging is used to obtain different medical images of animals for diagnosis of various chronic diseases. This veterinary imaging instrument is in high demand due to the increase in pet adoption and pet owners' focus on pet health. Veterinary imaging system is included various type of Imaging systems such as radiography, X-ray, MRI, CT imaging, endoscopy imaging, and ultrasound imaging ,this system is used to  diagnose diseases in livestock animals, companion animals, and large animals. Scanning is used to treat brain abnormalities, spinal herniation, brain tumors, brain and spinal cord trauma, ligament and tendon related problems in animals. Diagnostic imaging provides accurate information about structural or disease related changes. Increasing costs of pet insurance and animal health are increasing the demand for veterinary imaging. High demand for dairy and meat products, rising population of livestock, increase in awareness in pet owners regarding better treatments for pets, and increase in adoption of pets are other factors expected to drive growth of the global veterinary imaging market over the forecast period.

The report " Global Veterinary Imaging Market, By Product (Instrument, Reagents, Services), By Animal (Large Animals, Small Companion Animals, Others (Exotic Animals & Birds)), By Applications (Oncology, Orthopaedics and Traumatology, Neurology, Cardiology, Other (ophthalmology & dentistry)), By End User (Clinics & Hospitals, Reference Labs, and Other and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

In August 2022, SignalPET revolutionizes in-clinic diagnostics in the UK with AI powered radiology for IVC Evidensia.-- Evidensia has adopted new technology this technology is uses artificial intelligence to provide accurate and exceedingly rapid radiology readings, slashing diagnostic time from days to minutes. The point-of-care radiology technology, developed and patented by SignalPET, sends X-rays films through an AI Machine Learning technology to get the results back instantly, much quicker than sending them to a radiology specialist to analyze results, which can take up to three days.

Analyst View:

Veterinary imaging is a field of veterinary medicine that involves the collection of medical images of animals to diagnose diseases, bone fractures. And this imaging identify the problem in bones as well as tissues and can help with find out nerve damage and dysfunction. Increasing pet adoption and increase in the number of veterinarians worldwide is expected to increase the demand for these systems. The veterinary imaging market is expected to grow due to increased insurance coverage for domestic as well as livestock animals, due to high cost associated with imaging systems.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Veterinary Imaging Market, By Product (Instrument, Reagents, Services), By Animal (Large Animals, Small Companion Animals, Others (Exotic Animals & Birds)), By Applications (Oncology, Orthopaedics and Traumatology, Neurology, Cardiology, Other (ophthalmology & dentistry)), By End User (Clinics & Hospitals, Reference Labs, and Other) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4900

Key Market Insights from the report:

Global Veterinary Imaging Market accounted for US$ 1.5 billion in 2020 and is estimated to be US$ 3.00 billion by 2030 and is anticipated to register a CAGR of 7.3%. The Global Veterinary Imaging Market is segmented based on Product, Animal, Application, End User and Region.

·         Based on Product, Global Veterinary Imaging Market is segmented into Instrument, Reagents, and Services.

·         Based on Animal, Global Veterinary Imaging Market is segmented into Large Animals, Small Companion Animals, Others (Exotic Animals & Birds).

·         Based on Application, Global Veterinary Imaging Market is segmented into Oncology, Orthopaedics and Traumatology, Neurology, Cardiology, Other (ophthalmology & dentistry.

·         Based on End User, Global Veterinary Imaging Market is segmented into Clinics & Hospitals, Reference Labs, and Other.

·         By Region, the Global Veterinary Imaging Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Veterinary Imaging Market:

The prominent players operating in the Global Veterinary Imaging Market include GE Healthcare, Agfa Gevaert N.V., Carestream Health, Inc., Esaote S.p.A, IDEXX Laboratories, Inc., Mindray Medical International Limited, Canon Inc., Siemens Healthineers, FUJIFILM Holdings Corporation, Samsung Electronics Co. Ltd.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

·         Explains an overview of the product portfolio, including product development, planning, and positioning

·         Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.

·         Detailed analysis of the market revenue over the forecasted period.

·         Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.

·         Study on the segments that are anticipated to dominate the market.

·         Study on the regional analysis that is expected to register the highest growth over the forecast period

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Global Platelet Rich Plasma Market is estimated to be US$ 1003.06 million by 2030 with a CAGR of 11.50% during the forecast period.

Image
Global Platelet Rich Plasma Market accounted for US$ 337.23 million in 2020 and is estimated to be US$ 1003.06 million by 2030 and is anticipated to register a CAGR of 11.50%. Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is created by extracting red blood cells from blood. When the concentration of platelets in human blood is reduced, platelet-rich plasma is separated, which contains a concentration of platelets above typical values. Platelets thicken the blood and aid in the repair of muscles, ligaments, and tendons. They are extremely high in healing and connective tissue development factors. Platelet-rich plasma (PRP) blends the body's natural ability to heal itself with modern technologies. It has a wide range of medical applications, including neurology, orthopaedics, and ophthalmology. It's also employed in procedures like tendon repair and rotator cuff augmentation. The report   " Global Platelet Rich Plasma Market, By Type (Pure Platelet
Read more

Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Image
Neurodegenerative Disorder Therapeutics Market   accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7% The report " Global  Neurodegenerative Disorder Therapeutics Market, By  Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused on developing novel,
Read more

Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%

Image
  Systemic Lupus Erythematosus (SLE) is the chronic, autoimmune disorder which involves several organ-systems such as kidney, heart, blood, skin, joints, and lungs in most severe cases, brain. In this disease, the human immune system converts hyperactive and attacks the healthy, normal tissues of the body. SLE can often result in symptoms such as malar rash, sub-acute cutaneous lesions, discoid lesions, arthritis, photosensitivity, oral ulcers, serositis, nephropathy, thrombocytopenia, haemolytic anemia, neurologic involvement, fever, thrombosis, Raynaud’s phenomenon, livedo reticularis, and myositis. The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The report  " Global   Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, Intravenous, and
Read more